Article Text

Download PDFPDF
Hereditary diffuse gastric cancer syndrome: improved performances of the 2015 testing criteria for the identification of probands with a CDH1 germline mutation

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors Design of the study: PRB, ER, OC and MB. Genetic counselling and clinical management of patients: PRB, CC, JM, ADP, BB, DS-L, EM-F, CN, MDM, MW, SG, DM and OC. Gene analysis: CC, ER, NU, AR, QW and MB. Data collection: PRB, CC, ER, NU, PR, AR, QW, ADP, CT, MW and MB. Data analysis and interpretation: PRB and EMF. Drafting of the manuscript: PRB. Critical review and approval of the manuscript: all authors. Guarantor: PRB.

  • Competing interests None declared.

  • Ethics approval Gene analysis was prescribed by cancer geneticists within accredited, institution-approved, cancer genetics clinics. All participating laboratories were accredited by the French National Cancer Institute.

  • Provenance and peer review Not commissioned; externally peer reviewed.